谷歌浏览器插件
订阅小程序
在清言上使用

Abvd Plus Rituximab Versus Abvd Alone For Advanced Stage, High-Risk Classical Hodgkin Lymphoma: A Randomized Phase 2 Study

HAEMATOLOGICA(2019)

引用 8|浏览58
暂无评分
摘要
Based on several randomized studies comparing doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) with other multi-drug regimens, ABVD is the standard of care for newly diagnosed, advanced stage, classical Hodgkin lymphoma (cHL).[1][1] While the cure rate with ABVD approximates 75% in
更多
查看译文
关键词
ABVD,HL,RITUXIMAB
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要